Edition:
United States

Daito Pharmaceutical Co Ltd (4577.T)

4577.T on Tokyo Stock Exchange

2,303JPY
29 May 2017
Change (% chg)

-- (--)
Prev Close
¥2,303
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
47,313
52-wk High
¥3,030
52-wk Low
¥1,975

Summary

Name Age Since Current Position

Yasunobu Ohtsuga

62 2012 President, Representative Director

Masuo Nomura

2016 Executive Officer, Deputy Chief Director of Administration, Director of Finance

Hideyuki Kato

66 2011 Senior Managing Executive Officer, Chief Director of Drug Substance, Director

Junichi Kikuta

63 2013 Senior Managing Executive Officer, Chief Director of Research and Development, Director

Mitsuo Hirono

2017 Managing Executive Officer, Chief Director of Purchasing & Logistics

Masamichi Takimoto

2014 Managing Executive Officer, Chief Director of Pharmaceuticals

Hisao Abe

2014 Executive Officer, Deputy Chief Director of Administration, Director of Human Resources & General Affairs

Kenji Fujita

2012 Executive Officer, Chief Director of Purchase & Logistics

Kazushige Hizume

2016 Executive Officer, Deputy Chief Director of Pharmaceuticals, Director of Medical & Pharmaceutical

Hiroshi Kawahara

2013 Executive Officer

Kiyotaka Kido

2013 Executive Officer, Deputy Chief Director of Production, Director of Production Management

Hiroshi Kubota

2016 Executive Officer, Chief Director of Research & Development, Manager of Pharmaceutical Research Office

Yutaka Kuwashima

2016 Executive Officer, Manager of Business Planning Office

Kazutaka Nose

2012 Executive Officer, Chief Director of Overseas Business

Nobuya Oka

2017 Executive Officer, Chief Director of Overseas Business, President of Subsidiary

Tatsuo Shinohara

2016 Executive Officer, Chief Director of Pharmaceuticals

Hisao Takahashi

2016 Executive Officer, Chief Director of Reliability Guarantee

Daiki Takeda

Executive Officer, Chief Director of Drug Substance

Katsuya Tani

2016 Executive Officer, Chief Director of Production

Akihiko Yamada

2011 Executive Officer, Chief Director of Reliability Assurance

Yoshihiro Narai

72 2017 Director

Biographies

Name Description

Yasunobu Ohtsuga

Mr. Yasunobu Ohtsuga has been serving as President and Representative Director in Daito Pharmaceutical Co., Ltd. since August 28, 2012. He is also serving as Director in a subsidiary. He joined the Company in March 1975 and served as Director of Sales Planning, Managing Director, Senior Managing Director, Chief Director of Administration, Senior Managing Executive Officer and Manager of Business Planning Office in the Company. He obtained his Bachelor's degree in Pharmacy from Meiji Pharmaceutical University in March 1973.

Masuo Nomura

Hideyuki Kato

Mr. Hideyuki Kato has been serving as Senior Managing Executive Officer, Chief Director of Drug Substance and Director in Daito Pharmaceutical Co., Ltd. since August 26, 2011. He joined the Company in April 1971 and used to serve as Director of Drug Substance, Deputy Chief Director of Drug Substance and Managing Executive Officer in the Company.

Junichi Kikuta

Mr. Junichi Kikuta has been serving as Senior Managing Executive Officer, Chief Director of Research and Development and Director in Daito Pharmaceutical Co., Ltd. since August 29, 2013. He joined the Company in March 2010 and previously served as Executive Officer. He used to work for Takeda Pharmaceutical Company Limited.

Mitsuo Hirono

Masamichi Takimoto

Hisao Abe

Kenji Fujita

Kazushige Hizume

Hiroshi Kawahara

Kiyotaka Kido

Hiroshi Kubota

Yutaka Kuwashima

Kazutaka Nose

Nobuya Oka

Tatsuo Shinohara

Hisao Takahashi

Daiki Takeda

Katsuya Tani

Akihiko Yamada

Yoshihiro Narai

Mr. Yoshihiro Narai was named Director in Daito Pharmaceutical Co., Ltd. effective January 5, 2017. He used to work for Takeda Pharmaceutical Company Limited and served as President and Representative Director in NIHON PHARMACEUTICAL CO., LTD. He obtained his Bachelor's degree in Commerce from Keio University in March 1968.